AstraZeneca has launched FluMist Home, a nasal spray flu vaccine with at-home delivery service. For those who have a needle ...

If you are in one of 34 states, you can now order AstraZeneca's FluMist Home vaccine online to be delivered to your home ...

AstraZeneca has issued its flu vaccine nasal spray for at-home use. The nasal spray is authorized for use by adults ages 18-49 and for caregiver use with children ages 2-17, according to an Aug. 15 ...

By John Biju (Reuters) -Australian biotech firm CSL said on Tuesday it would spin off its influenza vaccine division and would cut up to 15% of its workforce as part of a strategic overhaul, sending ...

FLUMIST, AstraZeneca’s FDA-approved flu nasal vaccine, can now be ordered and used at home with zero needles or clinic hassle ...

The approval of the new nasal spray comes ahead of this year's influenza season in hopes to prevent the unusually high ...

Influenza Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical ...

Australian biotech giant CSL Ltd on Tuesday announced plans to demerge its influenza vaccine division, CSL Seqirus, and said it will lay off up to 15% of its workforce, after reporting a strong growth ...

HHS reinstates vaccine safety task force apparently in response to looming lawsuit deadline by group Secretary Kennedy ...